MENU
MYGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Myriad Genetics (MYGN) Ownership - Who owns Myriad Genetics?
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
320 Wakara Way
Phone
+1 801 584-3600
Employees
2700
Web
https://www.myriad.com
Details
Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
1.93B
P/E Ratio
N/A
Total Cash
140.9M
Projected Growth
1.24
Total Debt
152.1M
Revenue
753.2M
Risk (Beta)
2.05
Dividend Yield
N/A
Total Cash/Share
1.57
Total Debt/Equity
N/A
Revenue/Share
9.10 USD as % of share price
Fundamentals
MYGN
Capitalization
1.93B
P/E Ratio
N/A
Risk (Beta)
2.05
Dividend Yield
N/A
Total Cash
141M
Total Cash/Share
1.57
Total Debt
152M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.24
Revenue/Share (as % of the share price)
9.10%
Revenue
753M
ROE
N/A
Book Value
783M
P/B Ratio
2.46
Cash Flow
N/A
Earnings
-3.18
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
900K
Current Ratio
2.01
Current Revenue Per Employee
72814.81
Dividends Per Share - Security
N/A
EBITDA
-197.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
68.67
Revenue To Assets
-22.45
Shares Held By Institutions
3.88B
Shares Outstanding - Current
89.9M
Total Liabilities
363M
Total Volume MTD
N/A
Value
-1
Gain YTD
-25.748
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic and predictive medicine products
Industry MedicalSpecialties
Profile
Fundamentals
Details
Industry
Biotechnology
Address
320 Wakara Way
Phone
+1 801 584-3600
Employees
2700
Web
https://www.myriad.com